Response to methylphenidate in children with ADHD and comorbid anxiety

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 38, Issue 4, 1999, Pages 402-409

  Diamond, Ivan R ^a   Tannock, Rosemary ^a,b   Schachar, Russell J ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

Anxiety; Attention deficit hyperactivity disorder; Comorbidity; Methylphenidate

Indexed keywords

METHYLPHENIDATE;

ANXIETY NEUROSIS; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0033054728     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199904000-00012     Document Type: Article

References (26)

1. Ahmann PA, Waltonen SJ, Olson KA, Theye FW, Van Erem AJ, LaPlant RJ (1993), Placebo-controlled evaluation of Ritalin side effects. Pediatrics 91:1101-1106
2. American Psychiatric Association (1987), Diagnostic and Statistical Manual of Mental Disorders, 3rd edition-revised (DSM-III-R). Washington, DC: American Psychiatric Association
3. Barkley RA, McMurray MB, Edelbrock CS, Robbins K (1990), Side effects of methylphenidate in children with attention deficit hyperactivity disorder: systemic, placebo-controlled evaluation. Pediatrics 86:184-192
4. Biederman J, Newcorn J, Sprich S (1991), Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 148:564-577
5. DuPaul GJ (1991), The ADHD Rating Scale: normative data, reliability, and validity. In: Barkley R, Attention Deficit Hyperactivity Disorder: A Clinical Workbook. New York: Guilford
6. Jacobvitz D, Sroufe LA, Stewart M, Leffer N (1990), Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: a comprehensive review. J Am Acad Child Adolesc Psychiatry 29:677-688
7. Kashani JH, Orvaschel H, Burk JP, Red JC (1985), Informant variance: the issue of parent-child disagreement. J Am Acad Child Psychiatry 24:437-441
8. Livingstone RL, Dykman RA, Ackerman PT (1990), Psychiatric comorbidity and response to two doses of methylphenidate in children with attention deficit disorder. J Child Adolesc Psychopharmacol 2:115-122
9. Loney J, Milich R (1982), Hyperactivity, inattention and aggression in clinical practice. In: Advances in Developmental and Behavioral Pediatrics, Vol 3, Wolraich M, Routh D, eds. Greenwich, CT: JAI, pp 113-147
10. Overall JE, Doyle SR (1994), Repeated measurement sample sizes. Control Clin Trials 15:100-123
11. Pliszka SR (1989), Effect of anxiety on cognition, behavior and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry 28:882-887
12. Reynolds CR, Richmond BO (1985), Revised Children's Manifest Anxiety Scale (RCMAS) Manual. Los Angeles: Western Psychological Services
13. Reynolds CR, Richmond BO (1997), What I Think and Feel: A revised measure of children's manifest anxiety. J Abnorm Child Psychol 25:15-20
14. Russo MF, Beidel DC (1994), Comorbidity of childhood anxiety and externalizing disorder: prevalence, associated characteristics, and validation issues. Clin Psychol Rev 14:199-221
15. Safer DT, Zito JM, Fine EM (1996), Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 98:1084-1088
16. Schachar R, Tannock R, Cunningham C (1996), Treatment of childhood hyperactivity. In: Hyperactivity Disorders of Childhood, Sandberg S, ed. Cambridge, England: Cambridge University Press, pp 433-476
17. Schachar R, Tannock R, Marriott M, Logan G (1995), Deficient inhibitory control in attention deficit hyperactivity disorder. J Abnorm Child Psychol 23:411-437
18. Schachar RJ, Tannock R, Cunningham C, Corkum PV (1997), Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. J Am Acad Child Adolesc Psychiatry 36:754-763
19. Schachar RJ, Wachsmuth R (1989), Parent Interview for Child Symptoms-Revised DSM-III-R. Toronto: Department of Psychiatry, Hospital for Sick Children
20. Spencer T, Biederman J, Wilens T, Harding M, O'Dowell D, Griffin S (1996), Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 35:409-432
21. Szatmari P, Offord DR, Boyle MH (1989), Correlates, associated impairments and patterns of utilization of children with attention deficit disorder: findings from the Ontario Child Health Study. J Child Psychol Psychiatry 30:205-217
22. Tannock R (in press), Attention deficit disorder with anxiety disorders. In: Attention Deficit Disorders and Comorbidities in Children, Adolescents, and Adults. Brown TE, ed. Washington, DC: American Psychiatric Press
23. Tannock R, Ickowicz A, Schachar R (1995), Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 34:886-896
24. Tannock R, Schachar R (1992), Is ADHD with comorbid overanxious disorder different from ADHD? In: Comorbidity of ADHD: discriminating features and methodologic problems, Newcorn J (chair). Symposium conducted at the 39th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington, DC
25. Taylor E, Schachar R, Thorley G, Wieselberg HM, Everitt B, Rutter M (1987), Which boys respond to stimulant medication? A controlled trial of MPH in boys with disruptive behavior. Psychol Med 17:121-143
26. Wechsler D (1974), Wechsler Intelligence Scale for Children: Manual (Revised). New York: Psychological Corporation